ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival.

Francesca Fontana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.